Browsing Category

43904 posts
China Telecom's TeleNavi: Voice-Only Intelligent Location Technology Helps to Break Through 'The Digital Travel Dilemma' For the Elderly

China Telecom's TeleNavi: Voice-Only Intelligent Location Technology Helps to Break Through 'The Digital Travel Dilemma' For the Elderly

HONG KONG, Jan. 10, 2025 /PRNewswire/ —  The ‘Digital Travel Dilemma’ of…
HTX 2025 Outlook: Five Sectors to Look Forward to, and How Trump's Policy Will Affect Crypto Industry

HTX 2025 Outlook: Five Sectors to Look Forward to, and How Trump's Policy Will Affect Crypto Industry

SINGAPORE, Jan. 10, 2025 /PRNewswire/ — The year 2024 marks a significant chapter…
MLove's Rangers Series Shines at CES 2025, Redefining Music Experiences

MLove's Rangers Series Shines at CES 2025, Redefining Music Experiences

LAS VEGAS, Jan. 10, 2025 /PRNewswire/ — MLove, a leading audio brand, made…
ZWSOFT 2024 Year in Review: Empowering Sustainable Innovation

ZWSOFT 2024 Year in Review: Empowering Sustainable Innovation

GUANGZHOU, China, Jan. 10, 2025 /PRNewswire/ — 2024 marked a transformative year for ZWSOFT,…
CKGSB Professor Jin Zhao Becomes First Chinese Business School Scholar to Win AFA Award

CKGSB Professor Jin Zhao Becomes First Chinese Business School Scholar to Win AFA Award

BEIJING, Jan. 10, 2025 /PRNewswire/ — Professor JIN Zhao, Assistant Professor of Finance…
Youdao Dictionary Pen Unveils at CES 2025, Showcasing Cutting-Edge AI Innovations and Applications in Education

Youdao Dictionary Pen Unveils at CES 2025, Showcasing Cutting-Edge AI Innovations and Applications in Education

LAS VEGAS, Jan. 10, 2025 /PRNewswire/ — Youdao, a leading intelligent learning…
Vantage to Showcase Innovation at iFX EXPO Dubai 2025

Vantage to Showcase Innovation at iFX EXPO Dubai 2025

PORT VILA, Vanuatu, Jan. 10, 2025 /PRNewswire/ — Vantage Markets, a leading multi-asset…
JW Therapeutics Announces Receipt of Breakthrough Therapy Designation for Carteyva® in China as Second-line Treatment in Relapsed or Refractory adult Large B-cell Lymphoma

JW Therapeutics Announces Receipt of Breakthrough Therapy Designation for Carteyva® in China as Second-line Treatment in Relapsed or Refractory adult Large B-cell Lymphoma

SHANGHAI, Jan. 10, 2025 /PRNewswire/ — JW Therapeutics (HKEx: 2126), an independent and innovative biotechnology company…